Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
83.45
-0.69 (-0.82%)
At close: Dec 20, 2024, 4:00 PM
84.32
+0.87 (1.04%)
After-hours: Dec 20, 2024, 4:09 PM EST

Intra-Cellular Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-86.37-139.67-256.26-284.13-227.01-147.72
Upgrade
Depreciation & Amortization
0.540.530.660.530.530.48
Upgrade
Loss (Gain) From Sale of Investments
-8.58-8.40.45-4.08-0.65-1.13
Upgrade
Stock-Based Compensation
62.6552.9243.134.4824.3320.98
Upgrade
Change in Accounts Receivable
-42.94-38.83-55.03-9.39-10.77-
Upgrade
Change in Inventory
-11.03-26.35-15.97-0.89-7.06-
Upgrade
Change in Accounts Payable
-0.281.061.73.19-1.92-6.54
Upgrade
Change in Other Net Operating Assets
23.8634.5411.170.74-7.85.68
Upgrade
Operating Cash Flow
-62.16-124.2-270.19-259.54-230.07-127.98
Upgrade
Capital Expenditures
-0.75-0.27-0.78-0.33-0.27-0.7
Upgrade
Investment in Securities
-137.09105.81-127.6280.67-480.03178.14
Upgrade
Investing Cash Flow
-137.84105.54-128.37280.34-480.3177.44
Upgrade
Issuance of Common Stock
564.9117.81455.1611.52664.183.24
Upgrade
Financing Cash Flow
564.9117.81455.1611.52664.183.24
Upgrade
Net Cash Flow
364.91-0.8556.632.32-46.1952.69
Upgrade
Free Cash Flow
-62.91-124.47-270.96-259.87-230.34-128.68
Upgrade
Free Cash Flow Margin
-10.25%-26.80%-108.25%-310.10%-1009.69%-212303.69%
Upgrade
Free Cash Flow Per Share
-0.62-1.30-2.88-3.20-3.27-2.33
Upgrade
Cash Income Tax Paid
1.530.160.010.0100
Upgrade
Levered Free Cash Flow
-6.95-28.97-180.85-150.04-148.8-77.17
Upgrade
Unlevered Free Cash Flow
-6.95-28.97-180.85-150.04-148.8-77.17
Upgrade
Change in Net Working Capital
-6.64-17.4659.066.1828.871.67
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.